enGene Therapeutics, Inc. (ENGN)
1.56
-0.02
(-1.27%)
USD |
NASDAQ |
Oct 23, 16:00
1.565
0.00 (0.00%)
After-Hours: 20:00
enGene Therapeutics Price : 1.56 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 1.55 | 1.575 | 1.54 | 1.56 | 730199.0 |
| Oct 22, 2026 | 1.619 | 1.65 | 1.57 | 1.58 | 554579.0 |
| Oct 21, 2026 | 1.68 | 1.681 | 1.59 | 1.63 | 1.109M |
| Oct 20, 2026 | 1.60 | 1.72 | 1.59 | 1.67 | 1.120M |
| Oct 19, 2026 | 1.66 | 1.70 | 1.58 | 1.58 | 783845.0 |
| Oct 16, 2026 | 1.73 | 1.749 | 1.65 | 1.67 | 1.160M |
| Oct 15, 2026 | 1.61 | 1.735 | 1.58 | 1.71 | 1.177M |
| Oct 14, 2026 | 1.60 | 1.62 | 1.56 | 1.56 | 943530.0 |
| Oct 13, 2026 | 1.69 | 1.70 | 1.62 | 1.63 | 914086.0 |
| Oct 12, 2026 | 1.73 | 1.74 | 1.69 | 1.70 | 462719.0 |
| Oct 09, 2026 | 1.76 | 1.81 | 1.720 | 1.73 | 359126.0 |
| Oct 08, 2026 | 1.75 | 1.79 | 1.68 | 1.78 | 1.463M |
| Oct 07, 2026 | 1.80 | 1.859 | 1.74 | 1.745 | 708287.0 |
| Oct 06, 2026 | 1.87 | 1.87 | 1.80 | 1.80 | 361658.0 |
| Oct 05, 2026 | 1.94 | 1.94 | 1.785 | 1.87 | 952872.0 |
| Oct 02, 2026 | 2.00 | 2.02 | 1.93 | 1.94 | 692750.0 |
| Oct 01, 2026 | 2.01 | 2.01 | 1.96 | 1.98 | 903045.0 |
| Sep 30, 2026 | 1.965 | 2.02 | 1.93 | 2.00 | 1.283M |
| Sep 29, 2026 | 1.97 | 1.97 | 1.915 | 1.95 | 393184.0 |
| Sep 28, 2026 | 1.96 | 1.98 | 1.90 | 1.97 | 332186.0 |
| Sep 25, 2026 | 1.94 | 1.969 | 1.875 | 1.96 | 1.976M |
| Sep 24, 2026 | 1.99 | 1.99 | 1.905 | 1.92 | 796304.0 |
| Sep 23, 2026 | 2.05 | 2.05 | 1.98 | 2.00 | 669455.0 |
| Sep 22, 2026 | 1.96 | 2.08 | 1.96 | 2.05 | 1.066M |
| Sep 21, 2026 | 1.92 | 1.97 | 1.90 | 1.96 | 426340.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Aurinia Pharmaceuticals, Inc. | 16.86 |
| Medicus Pharma Ltd. | 2.50 |
| Xenon Pharmaceuticals, Inc. | 35.34 |
| Psyence Biomedical Ltd. | 4.165 |
| Agenus, Inc. | 6.33 |
Price Related Metrics
| PEG Ratio | -0.077 |
| Price to Book Value | 0.454 |
| Earnings Yield | -133.3% |
| Market Cap | 104.54M |
| PEGY Ratio | -0.077 |